Clinical trial
Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
NCT04819269 is registered in ClinicalTrials.gov with Sylentis, S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
- Lead sponsor
- Sylentis, S.A.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 25, 2021
- Completion date
- December 11, 2023
- Enrollment
- 203 (actual)
- Sites
- 46
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye disease, sjögren syndrome